21 October 2025

Last updated: Monday 20 October 2025

Research Directory

Diabetes reimbursement at risk in Germany

Unitary patent - for better or for worse?

2012 was the year of the antibody developer

Sofinnova's Investment Strategy: Putting the entrepreneur first

Are botanical drugs a new model for pharma?

Managers ignore pharmacovigilance at their peril

Adaptive licensing: A new approach for drug approvals

IMI: As Big Pharma pulls back, IMI steps in

MRC Technology: Going global for local returns

EU Transparency Directive: changes afoot on pricing and reimbursement